Larvol Delta - Centrexion-Therapeutics-Announces-Completion-of-Patient-Enrollment-in-Pivotal-Clinical-Trial-of-Repeat-Doses-of-CNTX4975-in-Patients-with-Moderate-to-Severe-Osteoarthritis-Knee-Pain

Adlea (capsaicin) - Arcion, Centrexion Corporation

http://www.globenewswire.com/news-release/2019/06/05/1864514/0/en/Centrexion-Therapeutics-Announces-Completion-of-Patient-Enrollment-in-Pivotal-Clinical-Trial-of-Repeat-Doses-of-CNTX-4975-in-Patients-with-Moderate-to-Severe-Osteoarthritis-Knee-Pa.html

Jun 5, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next